CD8A and neoplasm: Furthermore, mHTV-02 vaccination in animals with established tumors expressing HPV16 E6/E7 led to strong CD8+ T-cell infiltration and cytotoxicity in TC-1 tumors, robust memory T-cell immunity, accompanied by tumor regression and improved overall survival in tumor-bearing mice.